Balance and better interactions between primary-care and specialist physicians improve US health
...ialized countries. The study is published as a Web exclusive on Health Affairs' website March 15, 2005. "Decisions about the physician supply should be made on the basis of evidence for their utility in improving health and reducing ill health and deaths. Currently, the United States has many more specialists ...Three out of the four million newborn babies who die each year could be saved
...egnant women, promoting clean delivery, prompt and exclusive breastfeeding, extra care for low-birth-weight babies, and antibiotics for neonatal infection. The paper emphasises that combining interventions into packages, which are delivered within existing maternal care and child survival programs, will be mor...Promise of 'bladder pacemaker' for people with spinal cord injury
...founding partner in NDI Medical Company, which has exclusive license to the selective stimulation patent relevant to this research. NDI Medical is also the U.S. distributor of the Vocare device....A comprehensive response to HIV could prevent 10 million AIDS deaths in Africa by 2020
...ublished online January 11, 2005, suggests that an exclusive focus on one or the other of these alternatives will yield minimal benefits--failing to integrate the two approaches could have a catastrophic effect on the global toll of HIV/AIDS by 2020. In this modeling study the authors analyze the epidemic in s...Novartis announces collaboration with Bayer for EMSELEX
...orization for darifenacin, while Bayer Vital gains exclusive commercialization rights for EMSELEX in Germany. About EMSELEX EMSELEX is a once-daily M3 selective receptive antagonist (M3 SRA) oral treatment that works by selectively inhibiting the M3 receptor, the primary mediator of detrusor contraction, whi...Chemical cousin of anti-anxiety drugs holds promise for psoriasis treatment
...subsidiary of GMP Companies, Inc.) entered into an exclusive patent license and a sponsored research agreement with the University of Michigan to develop Bz-423 and other compounds for treatment of lupus, rheumatoid arthritis, psoriasis and some forms of cancer. Glick and collaborators at U-M also are using th...Two days of post-surgical pain relief now possible with just one shot
...a Inc. (LSE: SKP; Nasdaq: SKYE). Endo licensed the exclusive rights to market DepoDur in the U.S. and Canada from SkyePharma in December 2002 when the product was in Phase III clinical trial development. The May 18, 2004 FDA approval of DepoDur was based on clinical data showing significantly improved outcomes...Study examines nature and prevalence of errors in patient care
..."Given the prevalence of other types of errors, an exclusive focus on medication administration errors, often a typical practice, may miss many important and potentially hazardous situations," said Ann E. Rogers, an associate professor in Penn's School of Nursing. The findings are presented this month in the...Brookhaven Lab and BioSET develop a synthetic peptide that enhances the effect of BMP-2
...d by recombinant protein techniques. BioSET has an exclusive license to develop and market these bioactive analogs. Thomas Rouech, BioSET's president, said, "We are fortunate to enjoy a fruitful collaboration. This class of peptide and others under development supports the concept of design-targe...Some antibiotic resistance threat in hospitals could yield to hand washing
...se. The Hopkins team discovered that there was no exclusive or clear association in their patient population between those given antibiotics and those who acquire S. aureus bacteria resistant to methicillin. MRSA infections can cause serious pneumonia or surgical wound infections, says Song. Although patients...DepoDur found to be innovative option for postoperative pain relief
...greement with SkyePharma, Endo Pharmaceuticals has exclusive rights to market DepoDur TM in the U.S. and Canada. For complete prescribing information, please visit www.depodur.com. * DepoDur TM is not FDA-approved at the 5, 25 or 30 mg doses. It is FDA-approved at the 10, 15 and 20 mg doses. ...Department of Energy announces new agreement with USC, national labs and private company
...s. In addition, Second Sight will obtain a limited exclusive license for inventions developed during the artificial retina project. "This collaboration is very unique in that it taps the incredible engineering know-how of the Department of Energy labs, which have some of the most advanced engineering cap...DOE labs, universities and second sight partner to speed development of 'artificial retina'
... Inc. based in Sylmar, Calif., to obtain a limited exclusive license for inventions developed during the artificial retina project. Under the research agreements, the institutions will jointly share intellectual property rights and royalties from their research. This will speed progress by freeing the resea...Livermore scientists join DOE consortium
...roducts Inc. of Sylmar, Calif. to obtain a limited exclusive license for inventions developed during the DOE Retinal Prosthesis Project. "The Department of Energy has led the way to many scientific breakthroughs, especially when several scientific disciplines combined to make a whole greater than the sum of...Change in polio vaccine policy eliminates cases of vaccine-associated polio in US
...iovirus vaccine (IPV) followed by OPV. In 2000, an exclusive IPV schedule was adopted. Lorraine Nino Alexander, M.P.H., of the Centers for Disease Control and Prevention, Atlanta, and colleagues reviewed national polio surveillance data in the United States from 1990 through 2003, examining the epidemiology of...Study measures risks of exclusive pipe smoking
... use. To better estimate the risks associated with exclusive pipe smoking, Jane Henley of the American Cancer S...ase, and chronic obstructive pulmonary disease) in exclusive pipe smokers compared with nonsmokers. Current pipe smoking was associated with an increased risk of...Study: Low-carb diet more effective than low-fat diet
...stigator for the study. The researchers maintained exclusive control of all data and analyses....Preliminary results are promising in Alzheimer's gene therapy trial
...lds the patent to this therapeutic technology. The exclusive world-wide licensee is Ceregene, Inc. a San Diego-based biotechnology company focused on the development and commercialization of gene therapies for neurological disorders including Alzheimer's disease, Parkinson's disease and amyotrophic lateral scl...Preschoolers lead growth of antidepressant use, study reveals
...ents. "There are two differing but not mutually exclusive viewpoints on the increased use of antidepressants in children and adolescents," said Delate. "One is the concern that antidepressants are being prescribed to youths without adequate information about their safety and efficacy in this population. Th......g range berms. Today, HydroGlobe, as the sole and exclusive licensee of water technologies from Stevens Institute, has teamed with industry partners to supply products that efficiently and effectively remove heavy metals from water....